Sepragen

company

About

Sepragen provides break-through products and processes to the biotechnology and nutraceutical industries.

  • 11 - 50

Details

Last Funding Type
Grant
Last Funding Money Raised
$250K
Industries
Biotechnology,Manufacturing
Founded date
Jan 1, 1985
Number Of Employee
11 - 50
Operating Status
Active

Sepragen Corporation, based in Hayward, California, provides break-through products and processes to the biotechnology and nutraceutical industries for their process development and manufacturing needs. Their products enable their customers several fold higher productivity in a smaller footprint, ease of use and rapid, predictable scale up of processes from the laboratory to production. This results in lower capital outlay, lower cost of goods and rapid time to market. All products are designed and manufactured to the highest standards of quality and with the standards of traceability and cGMP compliance. Sepragen provides all the necessary documentation support and support services related to validation, IQ/OQ and follow on preventative maintenance.

In the biotechnology industry their products are used by industry leaders on four continents and are today used in making 24 FDA approved drugs. Sepragen’s growing menu of products includes both downstream and upstream products. All unique and backed by 16 patents these products include chromatography columns and accessories, column packing systems, chromatography systems, chromatography resins and bioreactors. As with its product portfolio Sepragen’s geographical footprint has also expanded with the addition of its latest manufacturing operation in India and a growing base of distributors.

Outside of biotechnology, Sepragen has developed and patented processes to isolate proteins from dairy whey, remove bitterness from citrus juices, isoflavones from soy and trace contaminants such as heavy metals and organics from process and ground water. Several of these processes have been licensed to third parties.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$474.99K
Sepragen has raised a total of $474.99K in funding over 2 rounds. Their latest funding was raised on Jun 21, 2017 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 21, 2017 Grant $224.99K 1 National Science Foundation Detail
Jun 19, 2013 Grant $250K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Sepragen is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant